Le Lézard
Classified in: Health, Science and technology, Business
Subject: CXP

TriNetX Moves to Expanded Headquarters in Cambridge


CAMBRIDGE, Mass., Oct. 19, 2017 /PRNewswire/ -- TriNetX, the global health research network for healthcare organizations, biopharmaceutical companies, and Contract Research Organizations (CROs), announced a move into their new, expanded headquarters in Cambridge to accommodate their rapidly growing business. The state of the art space promotes improved collaboration among the TriNetX team members and enhances TriNetX's ability to service its clients and partners.

TriNetX Lobby

The yearlong project involved moving from 8,200 square feet to a 20,000 square foot office space, upstairs in the same building at 125 Cambridgepark Drive. The TriNetX team has grown from 20 to 75 and the company had outgrown its existing space.

"We wanted to stay in Cambridge because of the proximity to our clients and partners, and it allows us to retain our talented group of employees," said Chris Fraser, Vice President, Finance & Administration who headed the relocation project. "It was equally important that the new space reflected our personality and aligned with our corporate values around teamwork, creativity and wellness."

The new space features an open office concept, but also includes numerous huddle rooms, phone rooms, conference rooms, and a library?all fully equipped with the latest in audio/video collaboration tools. Each workstation features a sit-to-stand option desk. The focal point of the new headquarters is a centrally located café that provides a convenient area for employees to interact out of the direct workspace.

A key feature of the new space is the Network Operations Center (NOC). This is a wall of large screen displays that monitor a variety of activities including the health of the network, real-time visibility to the TriNetX platform, and the operating status of the TriNetX appliances located at healthcare organizations all over the world.

"This allows us to keep a close eye on our network and systems," said Fraser. "It also helps us monitor our devices in the field to make sure they are operating properly. We can keep an eye on client activity so we are better prepared to respond to the needs of our clients and partners." 

TriNetX leveraged a team of vendors to help facilitate the move including Freudenheim Partners Real Estate, STV/DPM for project management, IA Interior Architects to help design the space, J. Calnan & Associates to build out the new offices, and Creative Office Pavilion to supply all the furniture and workstations.

About TriNetX
TriNetX is the global health research network enabling healthcare organizations, biopharma and contract research organizations (CROs) to collaborate, enhance trial design, accelerate recruitment and bring new therapies to market faster. Each member of our community shares in the consolidated value of our global, federated health research network that connects clinical researchers in real-time to the patient populations which they are attempting to study. For more information, you can follow us at @TriNetX on Twitter, LinkedIn, and/or visit https://www.trinetx.com/.

Media Contact:

Julia Weber
Racepoint Global
(617) 624-3234
[email protected]

TriNetX, Inc. Logo (PRNewsfoto/TriNetX)

SOURCE TriNetX


These press releases may also interest you

at 06:08
The Annual General Meeting of Bioretec Ltd was held on 26 April 2024 in Tampere, Finland. The Annual General Meeting approved the financial statements for the financial year 1 January?31 December 2023 and resolved to discharge the members of the...

at 06:00
IDEAYA Biosciences, Inc. , a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that, on April 25, 2024, the Compensation Committee of IDEAYA's Board of Directors granted...

at 06:00
-- Diluted EPS of $2.16; Adjusted Diluted EPS of $2.26 ---- Increases 2024 Full Year Guidance -- 2024 adjusted diluted EPS of $2.26, up over 7% from $2.11 in the first quarter of 2023.Increases 2024 full year adjusted diluted EPS guidance by $0.10 to...

at 06:00
Avantor, Inc. , a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today reported financial results for its first...

at 05:12
Swedish Orphan Biovitrum AB (publ) (Sobi®) has established a medium term note programme with a framework amount of SEK 10 billion or the equivalent thereof in EUR (the "MTN Programme"). For this purpose, Sobi has prepared a base prospectus, which...

at 04:00
OMRON Healthcare Co., Ltd. based in Muko, Kyoto Prefecture, Japan, announces to be the official sponsor of May Measurement Month (MMM,) a global campaign to raise awareness of blood pressure screening and promote hypertension prevention, detection,...



News published on and distributed by: